Log In
BCIQ
Print this Print this
 

Absorica, Epuris (Cip-isotretinoin)

  Manage Alerts
Collapse Summary General Information
Company Galephar Pharmaceutical Research Inc.
DescriptionOral semi-liquid capsule formulation of isotretinoin that uses the Lidose delivery system
Molecular Target Not available
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAcne
Indication DetailsTreat severe recalcitrant nodular acne
Regulatory Designation U.S. - Special Protocol Assessment (Treat severe recalcitrant nodular acne)
PartnerCipher Pharmaceuticals Inc.;
Sun Pharmaceutical Industries Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/05/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today